Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heart-Protecting Musk Pill for Diabetic Microangiopathy
NCT05095922Phase 4Completed
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Mar 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Shexiang Baoxin Pill in diabetic microangiopathy, sponsored by Affiliated Hospital of Nantong University. Started Mar 2023; status: completed.
02
Drugs
Shexiang Baoxin Pill
03
Conditions
diabetic microangiopathy
Beyond the preview
Go deeper on NCT05095922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095922.